Literature DB >> 2418049

Analgesic use in terminal cancer patients: report from the National Hospice Study.

R J Goldberg, V Mor, M Wiemann, D S Greer, J Hiris.   

Abstract

Little systematic research has been reported on analgesic use in terminal cancer patients. This paper presents data from the National Hospice Study on the use of analgesics by a sample of terminal cancer patients served in home based and hospital based hospice programs as well as conventional oncological settings. Patients in hospital based hospice programs were more likely than other patients to have an analgesic prescription and to have consumed analgesics. Patients in hospice settings were more likely to consume analgesia orally and less likely to have "prn" (as needed) analgesic prescriptions. The amount of analgesic consumption was inversely related to age. The paper discusses the implications of these and other findings for the treatment of pain in terminal cancer patients.

Entities:  

Keywords:  Death and Euthanasia; Empirical Approach; National Hospice Study; Professional Patient Relationship

Mesh:

Substances:

Year:  1986        PMID: 2418049     DOI: 10.1016/0021-9681(86)90105-0

Source DB:  PubMed          Journal:  J Chronic Dis        ISSN: 0021-9681


  3 in total

1.  Extensions to regret-based decision curve analysis: an application to hospice referral for terminal patients.

Authors:  Athanasios Tsalatsanis; Laura E Barnes; Iztok Hozo; Benjamin Djulbegovic
Journal:  BMC Med Inform Decis Mak       Date:  2011-12-23       Impact factor: 2.796

Review 2.  Effectiveness and cost-effectiveness of home palliative care services for adults with advanced illness and their caregivers.

Authors:  Barbara Gomes; Natalia Calanzani; Vito Curiale; Paul McCrone; Irene J Higginson
Journal:  Cochrane Database Syst Rev       Date:  2013-06-06

3.  Measuring symptoms in terminal cancer: are pain and dyspnoea controlled?

Authors:  I Higginson; M McCarthy
Journal:  J R Soc Med       Date:  1989-05       Impact factor: 18.000

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.